These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2860592)

  • 1. Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13.
    Baskin DS; Kuroda H; Hosobuchi Y; Lee NM
    Neuropeptides; 1985 Feb; 5(4-6):307-10. PubMed ID: 2860592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival.
    Baskin DS; Hosobuchi Y; Grevel JC
    J Neurosurg; 1986 Jan; 64(1):99-103. PubMed ID: 3941353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin(1-13) improves survival in cats with focal cerebral ischaemia.
    Baskin DS; Hosobuchi Y; Loh HH; Lee NM
    Nature; 1984 Dec 6-12; 312(5994):551-2. PubMed ID: 6150441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone.
    Vanderah TW; Laughlin T; Lashbrook JM; Nichols ML; Wilcox GL; Ossipov MH; Malan TP; Porreca F
    Pain; 1996 Dec; 68(2-3):275-81. PubMed ID: 9121815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats.
    Baskin DS; Widmayer MA; Browning JL; Heizer ML; Schmidt WK
    Stroke; 1994 Oct; 25(10):2047-53; discussion 2054. PubMed ID: 7916503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat.
    Obana WG; Pitts LH; Nishimura MC
    J Neurosurg; 1988 Jul; 69(1):98-103. PubMed ID: 3132541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
    Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
    Fujimoto JM; Rady JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers.
    Arcaya JL; Cano G; Gómez G; Maixner W; Suárez-Roca H
    Eur J Pharmacol; 1999 Jan; 366(1):27-34. PubMed ID: 10064148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
    Yurdaydin C; Li Y; Ha JH; Jones EA; Rothman R; Basile AS
    J Pharmacol Exp Ther; 1995 Apr; 273(1):185-92. PubMed ID: 7714765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dynorphin (1-8) on movement: non-opiate effects and structure-activity relationship.
    Friederich MW; Friederich DP; Walker JM
    Peptides; 1987; 8(5):837-40. PubMed ID: 2893358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors.
    Laughlin TM; Vanderah TW; Lashbrook J; Nichols ML; Ossipov M; Porreca F; Wilcox GL
    Pain; 1997 Aug; 72(1-2):253-60. PubMed ID: 9272810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
    Hauser KF; Foldes JK; Turbek CS
    Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid binding in a rat neurohypophysial fraction enriched in oxytocin and vasopressin nerve endings.
    Falke N; Martin R
    Neurosci Lett; 1985 Oct; 61(1-2):37-41. PubMed ID: 2867504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate modulation of dynorphin conversion in primary cultures of rat cerebral cortex.
    Vlaskovska M; Nylander I; Schramm M; Hahne S; Kasakov L; Silberring J; Terenius L
    Brain Res; 1997 Jun; 760(1-2):85-93. PubMed ID: 9237522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naloxone and opioid agonists on gastric excitatory responses to stimulation of the vagus nerve in cats.
    Okamoto T; Kurahashi K; Fujiwara M
    Br J Pharmacol; 1988 Oct; 95(2):329-34. PubMed ID: 2906554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.